Circio Holding ASA (OSL:CRNA) EBITDA Margin %: 0.00% (As of Dec. 2025)


OSL:CRNA Circio Holding ASA OSL:CRNA
26 GF Score
Price kr7.34
! 3 Warning Signs
View Full Analysis

What is Circio Holding ASA EBITDA Margin %?

Circio Holding ASA OSL:CRNA -0.27% 26 EBITDA Margin % is 0.00% as of Dec. 2025. GuruFocus rates OSL:CRNA with a GF Score™ of 26/100. The stock has 3 warning signs investors should review. Among 937 Biotechnology companies, Circio Holding ASA ranks worse than 106723.48% on this metric.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Circio Holding ASA's EBITDA for the six months ended in Dec. 2025 was kr-25.39 Mil. Circio Holding ASA's Revenue for the six months ended in Dec. 2025 was kr0.00 Mil. Therefore, Circio Holding ASA's EBITDA margin for the quarter that ended in Dec. 2025 was 0.00%.

Circio Holding ASA  (OSL:CRNA) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Circio Holding ASA EBITDA Margin % Related Terms

Circio Holding ASA EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Circio Holding ASA's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Circio Holding ASA EBITDA Margin % Chart

Circio Holding ASA Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 -976.41 -87,488.62 0.00 0.00

Circio Holding ASA Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -31,029.27 0.00 0.00 0.00 0.00

OSL:CRNA vs VRTX, REGN, ALNY: EBITDA Margin % Comparison

For the Biotechnology subindustry, Circio Holding ASA's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Circio Holding ASA EBITDA Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Circio Holding ASA's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Circio Holding ASA's EBITDA Margin % falls into.


OSL:CRNA
26GF Score
Circio Holding ASA OSL:CRNA
EBITDA Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Circio Holding ASA EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Circio Holding ASA's EBITDA Margin % for the fiscal year that ended in Dec. 2025 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-45.713/0
= %

Circio Holding ASA's EBITDA Margin % for the quarter that ended in Dec. 2025 is calculated as

EBITDA Margin %=EBITDA (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-25.391/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 0.00% mean?
Circio Holding ASA (OSL:CRNA) has a EBITDA Margin % of 0.00% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Circio Holding ASA and its competitors. According to the industry distribution chart, Circio Holding ASA ranks #999999 out of 937 companies in the Biotechnology industry.
Is Circio Holding ASA's EBITDA Margin % too high?
Circio Holding ASA's current EBITDA Margin % is 0.00%. Based on the distribution chart, Circio Holding ASA ranks #999999 out of 937 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Circio Holding ASA has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Circio Holding ASA's EBITDA Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Circio Holding ASA ranks #999999 out of 937 companies for EBITDA Margin %. This places Circio Holding ASA in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Biotechnology company?
A good EBITDA Margin % depends on the Biotechnology industry context. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Circio Holding ASA and its competitors. Circio Holding ASA's current EBITDA Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Circio Holding ASA stock overvalued right now?
Circio Holding ASA (OSL:CRNA) has a current EBITDA Margin % of 0.00%. The current EBITDA Margin % is 0.00%. Circio Holding ASA's overall GF Score™ is 26/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Circio Holding ASA (OSL:CRNA), the current EBITDA Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Circio Holding ASA Business Description

Other Exchanges 0RIS:UKTA50:Germany
Address c/o Mesh Community AS, Tordenskiolds Gate 2, Oslo, NOR, 0160
Circio Holding ASA is a biotechnology company developing circular RNA expression technology for gene and cell therapy applications. It has developed a circular RNA (circRNA) vector expression platform known as circVec, which is based on modular genetic constructs designed for circRNA production within target cells. The platform is being developed for applications including genetic medicine, cell therapy, and chronic disease treatment. The company's activities also include the development of RNA, DNA, and viral therapeutic technologies related to gene expression and protein production.
26GF Score

Get the complete analysis for OSL:CRNA

EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr7.34
Price